Neural Therapies is a privately-owned company which is focused on screening molecules as putative anti-stroke drugs. Neural Therapies independence of any pharmaceutical companies or other CROs guarantees the abscence of any conflict of interest in project discussions and reports to our customers.
Neural Therapies is a spin-off of the University of León based on the know-how developed for over more than 10 years of experience in stroke research by an interdisciplinary team. This provides a panel of experts including human and animal clinics, animal welfare, cell and molecular biologists.
Our clients benefit from a custom-based project design by a multidisciplinary group.
Contact us through:
email@example.com or +34 987 291 485